Use of expandable stents in the esophagus
- Todd H Baron, MD
Todd H Baron, MD
- Director of Advanced Therapeutic Endoscopy
- University of North Carolina, Chapel Hill
Expandable metal stents are now commonly used as a non-surgical alternative for the palliation of luminal gastrointestinal neoplasms, particularly esophageal cancer. Esophageal cancer is often diagnosed at an advanced stage, and stents can be useful for symptom palliation in patients with locally unresectable or advanced metastatic esophageal cancer, those with poor functional status who cannot tolerate surgery or chemoradiotherapy, or for those with locally recurrent disease after primary treatment. These patients generally have weight loss and dysphagia due to esophageal obstruction. Furthermore, cough and/or aspiration may be the result of a tracheoesophageal fistula, either as a complication of the tumor or its treatment.
Although less effective than when used for the treatment of distal esophageal obstruction, expandable metal stents can be placed successfully in patients with proximal or cervical esophageal malignant strictures .
Esophageal stents may provide palliation of dysphagia caused by extraesophageal malignancies that compress the esophagus extrinsically. However, symptom improvement is significantly less in this setting than in patients with intrinsic esophageal lesions . In addition, self-expandable stents are being used to treat benign esophageal disorders such as esophageal leaks, fistulas, and refractory strictures .
This topic will review the use of expandable stents in the treatment of esophageal obstruction from esophageal cancer and extrinsic esophageal compression from extraesophageal malignancies. A general overview of several methods of endoscopic palliation for esophageal cancer and the use of expandable stents in other portions of the gastrointestinal tract are discussed elsewhere. (See "Endoscopic palliation of esophageal cancer" and "Enteral stents for the palliation of malignant gastroduodenal obstruction" and "Enteral stents for the management of malignant colorectal obstruction" and "Endoscopic stenting for malignant pancreaticobiliary obstruction".)
TYPES OF STENTS
There are three types of expandable stents: metal, plastic, and biodegradable.
- Bethge N, Sommer A, Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal strictures near the upper esophageal sphincter. Gastrointest Endosc 1997; 45:300.
- Bethge N, Sommer A, Vakil N. Palliation of malignant esophageal obstruction due to intrinsic and extrinsic lesions with expandable metal stents. Am J Gastroenterol 1998; 93:1829.
- Sharma P, Kozarek R, Practice Parameters Committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 2010; 105:258.
- Dormann AJ, Eisendrath P, Wigginghaus B, et al. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy 2003; 35:207.
- Decker P, Lippler J, Decker D, Hirner A. Use of the Polyflex stent in the palliative therapy of esophageal carcinoma: results in 14 cases and review of the literature. Surg Endosc 2001; 15:1444.
- Bethge N, Vakil N. A prospective trial of a new self-expanding plastic stent for malignant esophageal obstruction. Am J Gastroenterol 2001; 96:1350.
- Costamagna G, Shah SK, Tringali A, et al. Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures. Surg Endosc 2003; 17:891.
- Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 2007; 102:2667.
- Verschuur EM, Repici A, Kuipers EJ, et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008; 103:304.
- Adler DG, Fang J, Wong R, et al. Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy. Gastrointest Endosc 2009; 70:614.
- Siddiqui AA, Glynn C, Loren D, Kowalski T. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study. Dis Esophagus 2009; 22:216.
- Bower M, Jones W, Vessels B, et al. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy. Ann Surg Oncol 2009; 16:3161.
- Brown RE, Abbas AE, Ellis S, et al. A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg 2011; 212:582.
- Hirdes MM, Siersema PD, van Boeckel PG, Vleggaar FP. Single and sequential biodegradable stent placement for refractory benign esophageal strictures: a prospective follow-up study. Endoscopy 2012; 44:649.
- Hirdes MM, van Hooft JE, Wijrdeman HK, et al. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer. Gastrointest Endosc 2012; 76:267.
- Canena JM, Liberato MJ, Rio-Tinto RA, et al. A comparison of the temporary placement of 3 different self-expanding stents for the treatment of refractory benign esophageal strictures: a prospective multicentre study. BMC Gastroenterol 2012; 12:70.
- ASGE Technology Committee, Tokar JL, Banerjee S, et al. Drug-eluting/biodegradable stents. Gastrointest Endosc 2011; 74:954.
- van Boeckel PG, Vleggaar FP, Siersema PD. A comparison of temporary self-expanding plastic and biodegradable stents for refractory benign esophageal strictures. Clin Gastroenterol Hepatol 2011; 9:653.
- van Hooft JE, van Berge Henegouwen MI, Rauws EA, et al. Endoscopic treatment of benign anastomotic esophagogastric strictures with a biodegradable stent. Gastrointest Endosc 2011; 73:1043.
- Repici A, Vleggaar FP, Hassan C, et al. Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest Endosc 2010; 72:927.
- Stivaros SM, Williams LR, Senger C, et al. Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures. Eur Radiol 2010; 20:1069.
- Fujii LL, Bonin EA, Baron TH, et al. Utility of an endoscopic suturing system for prevention of covered luminal stent migration in the upper GI tract. Gastrointest Endosc 2013; 78:787.
- Irani S, Baron TH, Gluck M, et al. Preventing migration of fully covered esophageal stents with an over-the-scope clip device (with videos). Gastrointest Endosc 2014; 79:844.
- Jacobson BC, Hirota W, Baron TH, et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2003; 57:817.
- Acunaş B, Rozanes I, Akpinar S, et al. Palliation of malignant esophageal strictures with self-expanding nitinol stents: drawbacks and complications. Radiology 1996; 199:648.
- Saxon RR, Morrison KE, Lakin PC, et al. Malignant esophageal obstruction and esophagorespiratory fistula: palliation with a polyethylene-covered Z-stent. Radiology 1997; 202:349.
- Ell C, May A, Hahn EG. Gianturco-Z stents in the palliative treatment of malignant esophageal obstruction and esophagotracheal fistulas. Endoscopy 1995; 27:495.
- Winkelbauer FW, Schöfl R, Niederle B, et al. Palliative treatment of obstructing esophageal cancer with nitinol stents: value, safety, and long-term results. AJR Am J Roentgenol 1996; 166:79.
- Rozanes I, Poyanli A, Acunaş B. Palliative treatment of inoperable malignant esophageal strictures with metal stents: one center's experience with four different stents. Eur J Radiol 2002; 43:196.
- Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001; 54:145.
- Raijman I, Siddique I, Ajani J, Lynch P. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc 1998; 48:172.
- Morgan RA, Ellul JP, Denton ER, et al. Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology 1997; 204:527.
- Verschuur EM, Kuipers EJ, Siersema PD. Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 2007; 66:1082.
- Im JP, Kang JM, Kim SG, et al. Clinical outcomes and patency of self-expanding metal stents in patients with malignant upper gastrointestinal obstruction. Dig Dis Sci 2008; 53:938.
- Dai Y, Li C, Xie Y, et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 2014; 10:CD005048.
- Amdal CD, Jacobsen AB, Sandstad B, et al. Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial. Radiother Oncol 2013; 107:428.
- Battersby NJ, Bonney GK, Subar D, et al. Outcomes following oesophageal stent insertion for palliation of malignant strictures: A large single centre series. J Surg Oncol 2012; 105:60.
- Kim ES, Jeon SW, Park SY, et al. Comparison of double-layered and covered Niti-S stents for palliation of malignant dysphagia. J Gastroenterol Hepatol 2009; 24:114.
- Siddiqui AA, Sarkar A, Beltz S, et al. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointest Endosc 2012; 76:44.
- Van Heel NC, Haringsma J, Spaander MC, et al. Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy. Gastrointest Endosc 2010; 72:249.
- van Heel NC, Haringsma J, Spaander MC, et al. Esophageal stents for the relief of malignant dysphagia due to extrinsic compression. Endoscopy 2010; 42:536.
- Schubert D, Scheidbach H, Kuhn R, et al. Endoscopic treatment of thoracic esophageal anastomotic leaks by using silicone-covered, self-expanding polyester stents. Gastrointest Endosc 2005; 61:891.
- Langer FB, Wenzl E, Prager G, et al. Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent. Ann Thorac Surg 2005; 79:398.
- Hünerbein M, Stroszczynski C, Moesta KT, Schlag PM. Treatment of thoracic anastomotic leaks after esophagectomy with self-expanding plastic stents. Ann Surg 2004; 240:801.
- Gelbmann CM, Ratiu NL, Rath HC, et al. Use of self-expandable plastic stents for the treatment of esophageal perforations and symptomatic anastomotic leaks. Endoscopy 2004; 36:695.
- Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 2001; 344:1681.
- Baron TH. Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin N Am 2007; 17:83.
- Hendra KP, Saukkonen JJ. Erosion of the right mainstem bronchus by an esophageal stent. Chest 1996; 110:857.
- Ramirez FC, Dennert B, Zierer ST, Sanowski RA. Esophageal self-expandable metallic stents--indications, practice, techniques, and complications: results of a national survey. Gastrointest Endosc 1997; 45:360.
- Kinsman KJ, DeGregorio BT, Katon RM, et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc 1996; 43:196.
- Siersema PD, Hop WC, Dees J, et al. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 1998; 47:113.
- Sumiyoshi T, Gotoda T, Muro K, et al. Morbidity and mortality after self-expandable metallic stent placement in patients with progressive or recurrent esophageal cancer after chemoradiotherapy. Gastrointest Endosc 2003; 57:882.
- Nishimura Y, Nagata K, Katano S, et al. Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys 2003; 56:1327.
- Lecleire S, Di Fiore F, Ben-Soussan E, et al. Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer. Aliment Pharmacol Ther 2006; 23:1693.
- Park JY, Shin JH, Song HY, et al. Airway complications after covered stent placement for malignant esophageal stricture: special reference to radiation therapy. AJR Am J Roentgenol 2012; 198:453.
- Bick BL, Song LM, Buttar NS, et al. Stent-associated esophagorespiratory fistulas: incidence and risk factors. Gastrointest Endosc 2013; 77:181.
- Ludwig D, Dehne A, Burmester E, et al. Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol 1998; 13:583.
- May A, Hahn EG, Ell C. Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types implemented in 96 implantations. J Clin Gastroenterol 1996; 22:261.
- Lagattolla NR, Rowe PH, Anderson H, Dunk AA. Restenting malignant oesophageal strictures. Br J Surg 1998; 85:261.
- TYPES OF STENTS
- Self-expandable metal stents
- Self-expandable plastic stents
- Self-expandable biodegradable stents
- Comparison of expandable stents with other modalities for inoperable esophageal cancer
- - SEMS versus rigid plastic tubes
- - SEMS versus laser
- - SEMS versus brachytherapy
- Comparison of stents
- Stenting for patients undergoing neoadjuvant chemotherapy
- Stenting for esophageal cancer recurrence
- Stenting for extraesophageal compression
- Benign disease
- ADVERSE EVENTS
- Types of adverse events
- Esophagorespiratory fistulas
- Stent migration and occlusion
- Gastroesophageal reflux
- SAFETY OF MRI
- SUMMARY AND RECOMMENDATIONS